Chondrosarcoma
ICD-10 C41.9 · ICD-11 2B50

Treatment of Chondrosarcoma at the Skull Base

Chondrosarcoma arising at the skull base represents a clinically distinct scenario. The anatomical location often limits the extent of achievable resection, making the local treatment strategy especially important for long-term disease control.

Clinical Scenario

This protocol addresses chondrosarcoma with skull base involvement — a site where proximity to critical neurovascular structures constrains surgical options and where dedicated radiotherapy delivery plays a central role alongside surgery.

Treatment Approach (partial overview)

The approach combines surgery with high-dose radiotherapy delivered via specialised particle-beam techniques. The specific modality, sequencing, and technical parameters are detailed in the full protocol.

Complete regimen, technique selection, and clinical decision pathway available below ↓
Instant Access to Structured Evidence-Based Regimens
References

DOI: 10.1038/s41416-024-02868-4

High-dose radiotherapy is recommended for skull base chondrosarcomas and with surgery can achieve high (80–90%) local control rates.

In skull base chondrosarcomas or chordomas, surgery and PBT can achieve local control rates of approximately 70–90%.

View source ↗